Proteomic Analysis for Malonylastragaloside I in U937 Leukemia Cells by Modified Label-free Quantitative Strategy with LC Chip Q-TOF MS/MS

Chinese Journal of Natural Medicines

Volumn 9, Issue 4, 2011, Pages 305-316

  Peng, Yong Bo ^a   Zhou, Ping ^a   Chu, Chu ^a   Liu, E Hu ^a   Wen, Xiao Dong ^a   Liu, Qun ^a   Chen, Jun ^a   Gao, Ning ^c   Qi, Lian Wen ^a,b   Li, Ping ^a,b  

^a China Pharmaceutical University   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

^c CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Cell proliferation; Label free; LC Chip Q TOF; Malonylastragaloside I; Peptide spectral intensity

Indexed keywords

ANTINEOPLASTIC AGENT; ASTRAGALUS EXTRACT; CASPASE 3; CASPASE 9; MALONYLASTRAGALOSIDE 1; TERPENOID DERIVATIVE; UNCLASSIFIED DRUG;

ALGORITHM; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IC 50; LEUKEMIA CELL; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PROCESS OPTIMIZATION; PROTEIN EXPRESSION; PROTEOMICS; REPRODUCIBILITY; WESTERN BLOTTING;

EID: 79960408010     PISSN: 20956975     EISSN: 18755364     Source Type: Journal    
DOI: 10.1016/S1875-5364(11)60068-X     Document Type: Article

References (35)

1. Bantscheff M, Schirle M Quantitative mass spectrometry in proteomics: a critical review [J]. Anal Bioanal Chem 2007, 389:1017-1031.
2. Chen M, Ying W, Song Y, et al. Analysis of human liver proteome using replicate shotgun strategy [J]. Proteomics 2007, 7(14):2479-2488.
3. States DJ, Omenn GS, Blackwell TW, et al. Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study [J]. Nat Biotechnol 2006, 24(3):333-338.
4. Dicker L, Lin X, Ivanov AR Increased power for the analysis of label-free LC-MS/MS proteomic data by combining spectral counts and peptide peak attributes [J]. Mol Cell Proteomics 2010, 9(12):2704-2718.
5. Zybailov B, Coleman MK, Florens L, et al. Correlation of relative abundance ratios derived from peptide ion chromatograms and spectrum counting for quantitative proteomic analysis using stable isotope labeling [J]. Anal Chem 2005, 77(19):6218-6224.
6. Old WM, Meyer-Arendt K, Aveline-Wolf L, et al. Comparison of label-free methods for quantifying human proteins by shotgun proteomics [J]. Mol Cell Proteomics 2005, 4(10):1487-1502.
7. Yin H, Killeen K, Brennen R, et al. Microfluidic Chip for peptide analysis with an integrated HPLC column, sample enrichment column, and nanoelectrospray tip [J]. Anal Chem 2005, 77(2):527-533.
8. Chu C, Cai HX, Ren MT, et al. Characterization of novel astragaloside malonates from Radix Astragali by HPLC with ESI quadrupole TOF MS[J]. J Sep Sci 2010, 33(4-5):570-581.
9. Liu H, Sadygov RG, Yates JR A model for random sampling and estimation of relative protein abundance in shotgun proteomics [J]. Anal Chem 2004, 76(14):4193-4201.
10. Wang W, Zhou H, Lin H, et al. Quantification of proteins and metabolites by mass spectrometry without isotopic labeling or spiked standards [J]. Anal Chem 2003, 75(18):4818-4826.
11. Radulovic D, Jelveh S, Ryu S, et al. Informatics platform for global proteomic profiling and biomarker discovery using liquid chromatography-tandem mass spectrometry [J]. Mol Cell Proteomics 2004, 3(10):984-997.
12. Wang G, Wu WW, Zeng W, et al. Label-free protein quantification using LC-coupled ion trap or FT mass spectrometry: Reproducibility, linearity, and application with complex proteomes [J]. J Proteome Res 2006, 5(5):1214-1223.
13. Chen M, Ying WT, Fang QM, et al. The Evaluation and application of a label-free quantitative proteomic strategy based on LC-ESI-MS/MS [J]. Prog Biochem Biophy 2008, 35(4):401-409.
14. Kim HK, Park WS, Kang SH, et al. Mitochondrial alterations in human gastric carcinoma cell line [J]. Am J Physiol Cell Physiol 2007, 293(2):C761-C771.
15. Carlucci F, Marinello E, Tommassini V, et al. A 57-gene expression signature in B-cell chronic lymphocytic leukemia [J]. Biomed Pharmacother 2009, 63(9):663-671.
16. Chen A, Kaganovsky E, Rahimipour S, et al. Two forms of gonadotropin-releasing hormone (GnRH) are expressed in human breast tissue and overexpressed in breast cancer: a putative mechanism for the antiproliferative effect of GnRH by down-regulation of acidic ribosomal phosphoproteins P1 and P2 [J]. Cancer Res 2002, 62(4):1036-1044.
17. Fang C, Yi Z, Liu F, et al. Proteome analysis of human liver carcinoma Huh7 cells harboring hepatitis C virus subgenomic replicon [J]. Proteomics 2006, 6(2):519-527.
18. Tu L, Liu Z, He X, et al. Over-expression of eukaryotic translation initiation factor 4 gamma 1 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma [J]. Mol Cancer 2010, 16(9):78.
19. Takashima M, Kuramitsu Y, Yokoyama Y, et al. Proteomic profiling of heat shock protein 70 family members as biomarkers for hepatitis C virus-related hepatocellular carcinoma [J]. Proteomics 2003, 3(12):2487-2493.
20. Schittek B, Psenner K, Sauer B, et al. The increased expression of Y box-binding protein 1 in melanoma stimulates proliferation and tumor invasion, antagonizes apoptosis and enhances chemoresistance [J]. Int J Cancer 2007, 120(10):2110-2118.
21. Shiota M, Izumi H, Tanimoto A, et al. Programmed cell death protein 4 down-regulates Y-box binding protein-1 expression via a direct interaction with Twist1 to suppress cancer cell growth [J]. Cancer Res 2009, 69(7):3148-3156.
22. Howard BA, Furumai R, Campa MJ, et al. Stable RNA interference-mediated suppression of cyclophilin A diminishes non-small-cell lung tumor growth in vivo [J]. Cancer Res 2005, 65(19):8853-8860.
23. Choi KJ, Piao YJ, Lim MJ, et al. Overexpressed cyclophilin A in cancer cells renders resistance to hypoxia- and cisplatin-induced cell death [J]. Cancer Res 2007, 67(8):3654-3662.
24. Bauer K, Kretzschmar AK, Cvijic H, et al. Cyclophilins contribute to Stat3 signaling and survival of multiple myeloma cells [J]. Oncogene 2009, 28(31):2784-2795.
25. Sievers C, Billig G, Gottschalk K, et al. Prohibitins are required for cancer cell proliferation and adhesion [J]. PLoS One 2010, 5(9):e12735.
26. Kuramori C, Azuma M, Kume K, et al. Capsaicin binds to prohibitin 2 and displaces it from the mitochondria to the nucleus [J]. Biochem Biophys Res Commun 2009, 379(2):519-525.
27. Kim JW, Akiyama M, Park JH, et al. Activation of an estrogen/estrogen receptor signaling by BIG3 through its inhibitory effect on nuclear transport of PHB2/REA in breast cancer [J]. Cancer Sci 2009, 100(8):1468-1478.
28. Susini L, Besse S, Duflaut D, et al. TCTP protects from apoptotic cell death by antagonizing bax function [J]. Cell Death Differ 2008, 15(8):1211-1220.
29. Gnanasekar M, Thirugnanam S, Zheng G, et al. Gene silencing of translationally controlled tumor protein (TCTP) by siRNA inhibits cell growth and induces apoptosis of human prostate cancer cells [J]. Int J Oncol 2009, 34(5):1241-1246.
30. Motegi A, Liaw HJ, Lee KY, et al. Polyubiquitination of proliferating cell nuclear antigen by HLTF and SHPRH prevents genomic instability from stalled replication forks [J]. Proc Natl Acad Sci USA 2008, 105(34):12411-12416.
31. Pan TL, Hung YC, Wang PW, et al. Functional proteomic and structural insights into molecular targets related to the growth inhibitory effect of tanshinone IIA on HeLa cells [J]. Proteomics 2010, 10(5):914-929.
32. Tomas A, Futter C, Moss SE Annexin 11 is required for midbody formation and completion of the terminal phase of cytokinesis [J]. J Cell Biol 2004, 165(6):813-822.
33. Kim JK, Kim PJ, Jung KH, et al. Decreased expression of Annexin A10 in gastric cancer and its overexpression in tumor cell growth suppression [J]. Oncol Rep 2010, 24(3):607-612.
34. Liu Y, Zhu X, Zhu J, et al. Identification of differential expression of genes in hepatocellular carcinoma by suppression subtractive hybridization combined cDNA microarray [J]. Oncol Rep 2007, 18(4):943-951.
35. Chechlinska M, Siwicki JK, Gos M, et al. Molecular signature of cell cycle exit induced in human T lymphoblasts by IL-2 withdrawal [J]. BMC Genomics 2009, 10:261.